Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

brain metastases

  • You have access
    Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone
    JEROME H. CHECK, DIANE L. CHECK and NAOMI GANPO-NKEWNKWA
    Anticancer Research February 2026, 46 (2) 1153-1165; DOI: https://doi.org/10.21873/anticanres.18018
  • Open Access
    Gamma Knife Radiotherapy of Brain Metastasis Resection Cavities: Outcome Analysis of a Single-center Cohort
    ÀLEX GODÓ JIMÉNEZ, GERO WIEGER, STEFANIE BREHMER, A. YASSER ABOUMADIAN, FLORIAN STIELER, FRANK A. GIORDANO and ARNE MATHIAS RUDER
    Anticancer Research November 2025, 45 (11) 5019-5029; DOI: https://doi.org/10.21873/anticanres.17843
  • You have access
    Immunosuppressive State May Lead to Brain Metastases in Lung Squamous Cell Carcinoma: Gene Expression and Immunohistochemical Analysis
    YOUNG WHA KOH, JAE-HO HAN, SEOKJIN HAAM and HYUN WOO LEE
    Anticancer Research February 2025, 45 (2) 525-534; DOI: https://doi.org/10.21873/anticanres.17441
  • Open Access
    Tertiary Lymphoid Structures in Brain Metastases of Lung Cancer: Prognostic Significance and Correlation With Clinical Outcomes
    SHOTA NOHIRA, SHUNICHIRO KURAMITSU, MASASUKE OHNO, MITSUGU FUJITA, KIMIHIRO YAMASHITA, TORU NAGASAKA, SHOICHI HAIMOTO, NORIAKI SAKAKURA, HIROKAZU MATSUSHITA and RYUTA SAITO
    Anticancer Research August 2024, 44 (8) 3615-3621; DOI: https://doi.org/10.21873/anticanres.17184
  • You have access
    Survival Impact of Postoperative Whole-brain Radiotherapy and Systemic Chemotherapy After Surgical Resection of Brain Metastases
    HIROMASA YOSHIOKA, TAKESHI OKUDA, MITSUGU FUJITA, TAKAYUKI NAKAO and JUN C. TAKAHASHI
    Anticancer Research August 2024, 44 (8) 3663-3667; DOI: https://doi.org/10.21873/anticanres.17190
  • Open Access
    Genetic and Immunological Characterization of Brain Metastases from Solid Cancers
    SHOICHI DEGUCHI, YASUTO AKIYAMA, KOICHI MITSUYA, TOMOATSU IKEYA, CHIKAKO HOZUMI, AKIRA IIZUKA, HARUO MIYATA, CHIE MAEDA, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KENICHI URAKAMI, KEIICHI OHSHIMA, KOJI MURAMATSU, TAKASHI SUGINO, YASUHISA OHDE, YASUHIRO TSUBOSA, SEIICHIRO NISHIMURA and KEN YAMAGUCHI
    Anticancer Research May 2024, 44 (5) 1983-1994; DOI: https://doi.org/10.21873/anticanres.17001
  • Open Access
    Intraventricular Cerebral Metastases: A Comprehensive Systematic Review
    GIANLUCA SCALIA, MANIKON PULLAY SILVEN, ROBERTA COSTANZO, MASSIMILIANO PORZIO, ROSARIO MAUGERI, DOMENICO GERARDO IACOPINO, GIOVANNI FEDERICO NICOLETTI and GIUSEPPE EMMANUELE UMANA
    Anticancer Research February 2024, 44 (2) 453-462; DOI: https://doi.org/10.21873/anticanres.16833
  • Open Access
    Outcomes of 30 Gy/5 Fr Hypofractionated Stereotactic Radiation Therapy for Small Brain Metastases (≤2 cm)
    YOSHIHIRO KAWAI, SHUHEI ARAMAKI, TOMOSHIGE ISHIHARA, KOSUKE SUZUKI, TSUYOSHI OKAWA, ERIKO SATO, NAOFUMI OTA, TAKASHI KOSUGI, MORIKAZU AMANO and KENTA KONISHI
    Anticancer Research October 2023, 43 (10) 4543-4549; DOI: https://doi.org/10.21873/anticanres.16648
  • You have access
    Independent Validation of a Unifying Prognostic Model for Intracranial and Extracranial Metastasis-directed Radiotherapy
    CARSTEN NIEDER, LUKA STANISAVLJEVIC, BARD MANNSAKER and ELLINOR C. HAUKLAND
    Anticancer Research July 2023, 43 (7) 3167-3172; DOI: https://doi.org/10.21873/anticanres.16490
  • You have access
    Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases
    LEONIE JOHANNWERNER, ELISA M. WERNER, STEFAN JANSSEN, NATHAN Y. YU and DIRK RADES
    Anticancer Research June 2023, 43 (6) 2757-2762; DOI: https://doi.org/10.21873/anticanres.16443

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire